We've built software to streamline the prior authorization process for for life-changing specialty medications. Our software offers medical practices a cloud-based solution to submit, track, and manage prior authorizations across their many payers and drugs. By digitizing the current manual paper-and-fax-heavy process, our platform reduces the administrative burdens that make patient care worse and drive up costs.
Location: United States, California, San Francisco
Employees: 11-50
Total raised: $41M
Founded date: 2018
Investors 1
Date | Name | Website |
07.09.2024 | Questa Cap... | questacapi... |
Funding Rounds 3
Date | Series | Amount | Investors |
21.05.2024 | Series B | $17M | - |
02.06.2022 | Series A | $12M | - |
01.02.2022 | Series A | $12M | Clearlake ... |
Mentions in press and media 8
Date | Title | Description |
22.05.2024 | Revolutionizing Patient Access: SamaCare's $17 Million Investment to Transform Healthcare Processes | SamaCare, a groundbreaking cloud-based patient access platform specializing in specialty medications, has recently announced the successful closure of an oversubscribed $17 million Series B investment round. Led by new investor Questa Capit... |
21.05.2024 | SamaCare raises $17M to build out its prior authorization platform | The company will be expanding into other areas standing in the way of patients getting needed care While medication adherence, or getting people to fill their prescriptions, and then actually take their drugs, has been an issue for a very l... |
21.05.2024 | SamaCare Raises $17M in Series B Funding | SamaCare, a San Francisco, CA-based provider of a cloud-based patient access platform for specialty medications, raised $17M in Series B funding. The round was led by Questa Capital, with participation from existing investors Vive Collectiv... |
21.05.2024 | SamaCare Secures $17M to Scale Specialty Drug Prior Authorization Platform | What You Should Know: – SamaCare, a cloud-based patient access platform for specialty medications, today announced that it has closed an oversubscribed $17 million Series B investment round led by new investor Questa Capital. – Questa is jo... |
02.06.2022 | 3 reasons companies are still doing SPAC mergers | This is the web version of Term Sheet, a daily newsletter on the biggest deals and dealmakers. Sign up to get it delivered free to your inbox. Let’s take a brief stroll back to Aug. 2021, shall we? Paid Content How Northrop Grumman uses ESG... |
02.06.2022 | SamaCare Closes $12M Series A | SAN FRANCISCO, CA, SamaCare, a prior authorization platform for physician-administered medications, announced the close of a $12 million Series A funding. >> Click here for more funding data on SamaCare >> To export SamaCare... |
02.06.2022 | SamaCare raises $12M to streamline the prior authorization process | The company added Cheryl Cheng from Vive Collective to its board of directors One of the biggest burdens that medical providers face when trying to get patients onto new therapies is a process called prior authorization, meaning the paperwo... |
- | SamaCare | “SamaCare helps you spend less time with prior authorizations and more time with patients - at no cost for medical practices.” |